Navigation Links


Genzyme at Biology News

Genzyme at Biology Products
Genzyme at Biology Technology

Cytochroma settles lawsuit with Genzyme

The lawsuit, in which Genzyme claimed that the former Bone Care employees had begu...

Genzyme sues former Bone Care employees

. filed the suit in <a href="http://www.wiwd...

Genzyme acquistion of Bone Care approved, significant impact forecast

...
Genzyme at Medicine News

Genzyme Announces First Phase III Study of Tolevamer in Diarrhea Patients

Genzyme Corp. announced top-line data from the first of two Phase 3 clinical studies to assess the safety and efficacy of tolevamer liquid, an investigational, non-antibiotic , polymer therapy for patients with Clostridium difficile associated diarrhea (CDAD). The second Phase 3 study of tolevamer liquid is fully enrolled and results are expected later this year. In this first Phase...
Genzyme at Medicine Products
Genzyme at Medicine Technology

Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea

CAMBRIDGE, Mass., July 06, 2007 /PRNewswire-FirstCall/ --Genzyme Corp. announced top-line data today from the first of twoPhase 3 clinical studies to assess the safety and efficacy oftolevamer liquid, an investigational, non-antibiotic, polymertherapy for patients with Clostridium difficile associated diarrhea(CDAD). The second Phase 3 study of tolevamer liquid is fullyenrolled and resul...

Genzyme Announces Results of Clinical Trial of Hylastan

CAMBRIDGE, Mass., July 05, 2007 /PRNewswire-FirstCall/ --Genzyme Corp. today announced top-line results from a pivotal studyinvestigating the safety and efficacy of hylastan in treating painin patients with osteoarthritis (OA) of the knee. Hylastan is beingdeveloped within Genzyme's program to introduce aviscosupplementation product that can be delivered through a singleknee injection. T...

Genzyme Announces Results of Clinical Trials Investigating Powder Form of Sevelamer Carbonate

CAMBRIDGE, Mass., June 18, 2007 - Genzyme Corp. (Nasdaq: GENZ)today announced the results of two new studies comparing a powderform of Renvela™ (sevelamer carbonate) to Renagel®tablets (sevelamer hydrochloride), including one trial in whichpatients received the powder form three times per day, and one inwhich it was administered once per day. Genzyme is developing Renvela...

Genzyme Announces Results of Clinical Trials Investigating Powder Form of Sevelamer Carbonate

CAMBRIDGE, Mass., June 18, 2007 /PRNewswire-FirstCall/ --Genzyme Corp. today announced the results of two new studiescomparing a powder form of Renvela (sevelamer carbonate) to Renageltablets (sevelamer hydrochloride), including one trial in whichpatients received the powder form three times per day, and one inwhich it was administered once per day. Genzyme is developing Renvela in...

Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN

Interim analysis of Phase 2 comparative study showed significantresults in favor of alemtuzumab versus Rebif CAMBRIDGE, Mass. and WAYNE, N.J., May 02, 2007/PRNewswire-FirstCall/ -- Genzyme Corporation and Bayer HealthCarePharmaceutical today announced detailed interim results from theCAMMS223 Phase 2 study. This interim analysis of all patient datathrough at least twenty-four months from...

More>>

Other TagsVariousAfghanRecommended
(Date:8/20/2008)... and The Schmidt Firm, LLP represent Virginia man ...nt warnings. , San Diego,...erday filed what is believed to be the first perso...ed with the use of http://www.schmidtandclark.com...for diabetes. Victor Deleon alleges in a lawsuit ...
(Date:8/19/2008)...stCall/ -- ev3 Inc. (Nasdaq:,EVVV) today announced...ulie,Tracy, chief communications officer, are sche...thcare Unplugged Conference at 2:10 p.m. Eastern T...tt New York located at 109 East,42nd Street at Gra...ss the webcast, go to the investors, section of th...
(Date:8/19/2008)...l Storm Fay, WASHINGTON, Aug. 19 /PRNewswire-USNe...l Storm Fay continues her slow march up the Florid...helter for affected Florida,residents and has more...ns,materialize. Fay has left tens of thousands of ...y of flooding and isolated tornadoes is high as th...
(Date:8/19/2008)...ll/ -- Sunrise Senior Living,Inc. (NYSE: SRZ ) a...nt,directors to its board of directors effective A...vice president of Acquisitions and Development of,... chairman and CEO of,Office Depot, Inc., have been... office expires at Sunrise,s 2008 annual meeting o...
Breaking Medicine News(10 mins):Health News:Amylin Pharmaceuticals Diabetes Drug Byetta the Focus of California Lawsuit 2Health News:Red Cross Getting Ahead of Fay as More Rain Falls Across State 2Health News:Sunrise Senior Living Appoints Glyn Aeppel and David Fuente to its Board 2
(Date:8/19/2008)...HOUSTON -- Aug. 19, 2008 -- Using a combination of...ents, physical biochemists at Rice University have...is known to cause Wilson disease -- subtly changes...e body uses to keep copper from building up to tox... puzzle," said lead author Agustina Rodriguez-Gran...
(Date:8/19/2008)...HLAND, Wash. Scientists can learn how advances in...ms and expanding research horizons at an upcoming ...ational meeting in Philadelphia, Penn. The scienti... late Mike White at the symposium, which will be h...ly important when it comes to energy supply," said...
(Date:8/18/2008)...roduces new corporate product offerings and intern... products into South Africa and neighboring ... Aug. 18 /PRNewswire-FirstCall/ -- bioMETRX Inc., ...he assets of the former wholly,owned subsidiary of...ETRX,S.A. at the request of their secured credito...
(Date:8/18/2008)...ORLANDO, Fla., Aug. 18 /PRNewswire/ -- Central Flo...afe & Lock Co., has announced its strategic,allian.... Effective,immediately, all product and service l...ill be offered by Cuellar,s in conjunction with Ab...e and showroom location just blocks,away from the ...
Breaking Biology News(10 mins):Rice lab finds molecular clues to Wilson disease 2Catalysis takes center stage at chemistry conference 2Catalysis takes center stage at chemistry conference 3bioMETRX, Inc. Acquires Assets of Sequiam Biometrics (Pty) Ltd. 2bioMETRX, Inc. Acquires Assets of Sequiam Biometrics (Pty) Ltd. 3Cuellar's Safe and Lock Announces Strategic Alliance with Absolute Access and Security 2Indevus Pharmaceuticals Announces Retirement of David B Sharrock From Its Board of Directors 1415 1Indevus Pharmaceuticals Announces Retirement of David B Sharrock From Its Board of Directors 1415 2Indevus Pharmaceuticals Announces Retirement of David B Sharrock From Its Board of Directors 1415 3Thermo Fisher Scientific Advances Gene Silencing Technology for Life Sciences Research 597 1Thermo Fisher Scientific Advances Gene Silencing Technology for Life Sciences Research 597 2Thermo Fisher Scientific Advances Gene Silencing Technology for Life Sciences Research 597 3Weight gain related to postmenopausal breast cancer risk 4302 1Weight gain related to postmenopausal breast cancer risk 4302 2Fighting obesity may be as easy as ATP says UH researcher 4299 1Fighting obesity may be as easy as ATP says UH researcher 4299 2Fighting obesity may be as easy as ATP says UH researcher 4299 3
Other Contentsnormalizationnormalizationnormalizationnormalizationnorthernnorthernnorthernnorthernnorthernnostrilnostrilnotochordterminusterminusterminusacidsacidsacidsacidsacidsacidsacidsacidsacidsnucleicnucleicnucleicnucleicnucleicnucleicnucleicnucleicnucleicnucleoli